The Food and Drug Administration has cited a Raleigh, NC based pharmaceutical company with some misleading marketing of one of its products. Soltamox is marketed as an oral liquid formulation that is used to prevent and treat breast cancer. The FDA officials are saying that the marketing of the product omits some key facts and risk information, along with some other unsubstantiated claims.

Read the full article here:
FDA cites Dara BioSciences for misleading marketing of Soltamox – News & Observer